News

The Manila Times
manilatimes.net > 03/10/2026 > tmt-newswire > globenewswire > ardelyx-announces-publication-of-a-review-article-demonstrating-rapid-and-meaningful-symptom-relief-with-tenapanor-in-ibs-c > 2296373

Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C

1+ week, 1+ day ago  (233+ words) Post hoc analysis supports a reduction of time to first bowel movement and a consistent improvement in abdominal symptoms, including pain, discomfort, and bloating, during 12weeks of treatment Continued therapy through 12 weeks increased the likelihood of reporting meaningful symptom improvement and…...

The Manila Times
manilatimes.net > 03/07/2026 > tmt-newswire > globenewswire > tris-pharma-announces-positive-debut-data-from-phase-3-alleviate-1-and-2-trials-evaluating-cebranopadol-in-acute-pain-at-aapm-painconnect-2026-annual-meeting > 2295089

Tris Pharma Announces Positive Debut Data from Phase 3 ALLEVIATE-1 and 2 Trials Evaluating Cebranopadol in Acute Pain at AAPM PainConnect 2026 Annual Meeting

1+ week, 5+ day ago  (903+ words) Cebranopadol is an investigational first-of-its kind dual NOP/MOP receptor (NMR) agonist which uses a novel approach of activating NOP and MOP receptors to work synergistically to modulate painIn both ALLEVIATE trials cebranopadol demonstrates significant and sustained pain reduction with…...

The Manila Times
manilatimes.net > 02/17/2026 > tmt-newswire > globenewswire > fulcrum-therapeutics-to-present-12-week-data-from-the-20-mg-dose-cohort-of-the-phase-1b-pioneer-trial-of-pociredir-in-sickle-cell-disease > 2279488

Fulcrum Therapeutics to Present 12-Week Data from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease

1+ mon, 1+ day ago  (591+ words) Fulcrum Therapeutics to Present 12-Week Data from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease'The Manila Times Fulcrum Therapeutics to Present 12-Week Data from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial…...

The Manila Times
manilatimes.net > 02/02/2026 > tmt-newswire > globenewswire > scisparc-neurothera-labs-granted-us-patent-for-cannabinoid-technology-to-overcome-antimicrobial-resistance-such-as-mrsa > 2269812

SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA

1+ mon, 2+ week ago  (693+ words) (Nasdaq: SPRC) ("Company" or "SciSparc"), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for ... SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA NeuroThera's…...

The Manila Times
manilatimes.net > 02/17/2026 > tmt-newswire > globenewswire > press-release-sanofi-and-tevas-duvakitug-phase-2b-maintenance-data-demonstrated-clinically-meaningful-durable-efficacy-in-ulcerative-colitis-and-crohns-disease > 2279269

Press Release: Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease

1+ mon, 1+ day ago  (404+ words) Sanofi and Teva's duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn's disease These longer duration data reinforce the efficacy from the RELIEVE UCCD phase 2b induction study (clinical study identifier: NCT05499130), which demonstrated that patients achieved…...

The Manila Times
manilatimes.net > 02/09/2026 > tmt-newswire > globenewswire > best-thc-gummies-for-pain-relief-in-2026-budpop-ranked-no1-by-kstate-collegian > 2274084 > amp

Best THC Gummies for Pain Relief in 2026: Budpop Ranked No.1 by Kstate Collegian

1+ mon, 1+ week ago  (756+ words) The Kansas State Collegian ranks BudPop as the top THC gummy brand for pain after reviewing 50+ legal hemp-derived products nationwide. Read more Charlotte, NC, Feb. 09, 2026 (GLOBE NEWSWIRE) -- The Kansas State Collegian, a 130-year-old media outlet based in Kansas (United States),…...

The Manila Times
manilatimes.net > 01/29/2026 > tmt-newswire > pr-newswire > nextbiomedical-secures-health-canada-approval-for-nexsphere-f-in-musculoskeletal-pain-embolization > 2267991

NEXTBIOMEDICAL Secures Health Canada Approval for Nexsphere-F™ in Musculoskeletal Pain Embolization

1+ mon, 2+ week ago  (430+ words) **media[917919]**SEOUL, South Korea, Jan. 29, 2026 /PRNewswire/ -- NEXTBIOMEDICAL CO., LTD. (KOSDAQ: 389650), an innovative medical device company based in South Korea, announced today that Nexsphere-F, the company's novel fast resorbable microsphere for musculoskeletal pain embolization has received approval from Health Canada. Nexsphere-F…...

The Manila Times
manilatimes.net > 01/30/2026 > tmt-newswire > globenewswire > glucosamine-supplement-for-joints-a-nutraharmony-buyers-guide-glucosamine-chondroitin-collagen > 2268194

Glucosamine Supplement for Joints: A NUTRAHARMONY Buyer’s Guide (Glucosamine + Chondroitin + Collagen)

1+ mon, 2+ week ago  (1550+ words) NUTRAHARMONY Glucosamine, Chondroitin & Collagen Joint Support supplement, developed to support joint comfort, mobility, and long-term musculoskeletal health as part of a daily wellness routine. Mobility affects nearly every aspect of life - from basic movement and physical activity to work performance,…...

The Manila Times
manilatimes.net > 12/24/2025 > tmt-newswire > globenewswire > what-is-the-best-foot-massager-for-neuropathy-and-circulation-support-new-consumer-data-analysis-reveals-key-evaluation-criteria-as-at-home-therapy-demand-grows > 2249092

What Is the Best Foot Massager for Neuropathy and Circulation Support? New Consumer Data Analysis Reveals Key Evaluation Criteria as At-Home Therapy Demand Grows

2+ mon, 3+ week ago  (981+ words) CLAYMONT, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Why Are So Many People Searching for the "Best" Foot Massager Now? Foot discomfort, tingling, numbness, and swelling are increasingly common complaints as populations age and sedentary lifestyles reduce natural circulation to the extremities. According to…...

The Manila Times
manilatimes.net > 12/03/2025 > tmt-newswire > globenewswire > foot-renew-unveiled-how-the-rejuvacare-footrenew-massager-eases-neuropathy-pain-boosts-foot-circulation > 2235768

Foot Renew Unveiled: How The RejuvaCare FootRenew Massager Eases Neuropathy Pain & Boosts Foot Circulation

3+ mon, 2+ week ago  (1551+ words) What is RejuvaCare FootRenew?" As a result, FootRenew positions itself not merely as a foot-relief gadget, but as an all-in-one foot-health tool suitable for routine home therapy. RejuvaCare emphasizes that consistent use may help maintain long-term foot comfort, promote relaxed…...